Cargando…

Impact of R-Carvedilol on β2-Adrenergic Receptor-Mediated Spontaneous Calcium Release in Human Atrial Myocytes

A hallmark of atrial fibrillation is an excess of spontaneous calcium release events, which can be mimicked by β1- or β2-adrenergic stimulation. Because β1-adrenergic receptor blockers (β1-blockers) are primarily used in clinical practice, we here examined the impact of β2-adrenergic stimulation on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Casabella-Ramón, Sergi, Jiménez-Sábado, Verónica, Tarifa, Carmen, Casellas, Sandra, Lu, Tien Tina, Izquierdo-Castro, Paloma, Gich, Ignasi, Jiménez, Marcel, Ginel, Antonino, Guerra, José M., Chen, S. R. Wayne, Benítez, Raul, Hove-Madsen, Leif
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313410/ https://www.ncbi.nlm.nih.gov/pubmed/35885069 http://dx.doi.org/10.3390/biomedicines10071759

Ejemplares similares

Spatial Distribution of Calcium Sparks Determines Their Ability to Induce Afterdepolarizations in Human Atrial Myocytes
por: Tarifa, Carmen, et al.
Publicado: (2022)

Increased Density of Endogenous Adenosine A(2A) Receptors in Atrial Fibrillation: From Cellular and Porcine Models to Human Patients
por: Godoy-Marín, Héctor, et al.
Publicado: (2023)

Expression and Impact of Adenosine A(3) Receptors on Calcium Homeostasis in Human Right Atrium
por: Tarifa, Carmen, et al.
Publicado: (2023)

Influence of sex on intracellular calcium homoeostasis in patients with atrial fibrillation
por: Herraiz-Martínez, Adela, et al.
Publicado: (2021)

Identification of atrial-enriched lncRNA Walras linked to cardiomyocyte cytoarchitecture and atrial fibrillation
por: García-Padilla, Carlos, et al.
Publicado: (2022)

Carvedilol Prevents Redox Inactivation of Cardiomyocyte Β(1)-Adrenergic Receptors
por: Park, Misun, et al.
Publicado: (2018)

Dynamics of adrenergic signaling in cardiac myocytes and implications for pharmacological treatment
por: Meyer, Emily E., et al.
Publicado: (2021)

Chronic treatment with Carvedilol improves ventricular function and reduces myocyte apoptosis in an animal model of heart failure
por: Okafor, Chukwuka C, et al.
Publicado: (2003)

MARCH2 promotes endocytosis and lysosomal sorting of carvedilol-bound β(2)-adrenergic receptors
por: Han, Sang-oh, et al.
Publicado: (2012)

Differential effects of adrenergic antagonists (Carvedilol vs Metoprolol) on parasympathetic and sympathetic activity: a comparison of measures
por: Vinik, Aaron I., et al.
Publicado: (2014)

Effect of adrenergic blockers, carvedilol, prazosin, metoprolol and combination of prazosin and metoprolol on paracetamol-induced hepatotoxicity in rabbits
por: Zubairi, Maysaa B., et al.
Publicado: (2014)

The 4q25 variant rs13143308T links risk of atrial fibrillation to defective calcium homoeostasis
por: Herraiz-Martínez, Adela, et al.
Publicado: (2019)

Enantioselective Resolution of (R,S)-Carvedilol to (S)-(−)-Carvedilol by Biocatalysts
por: Ettireddy, Swetha, et al.
Publicado: (2017)

Differential effects of adrenergic antagonists (Carvedilol vs Metoprolol) on parasympathetic and sympathetic activity: a comparison of clinical results
por: Bloom, Heather L., et al.
Publicado: (2014)

Gα(i) is required for carvedilol-induced β(1) adrenergic receptor β-arrestin biased signaling
por: Wang, Jialu, et al.
Publicado: (2017)

Effect of beta‐adrenergic blockade with carvedilol on cachexia in severe chronic heart failure: results from the COPERNICUS trial
por: Clark, Andrew L., et al.
Publicado: (2017)

Carvedilol ameliorates dexamethasone-induced myocardial injury in rats independent of its action on the α1-adrenergic receptor
por: Mohamed, Rasha M. S. M., et al.
Publicado: (2022)

Nuclear Compartmentalization of α1-Adrenergic Receptor Signaling in Adult Cardiac Myocytes
por: Wu, Steven C., et al.
Publicado: (2015)

Ageing is associated with deterioration of calcium homeostasis in isolated human right atrial myocytes
por: Herraiz-Martínez, Adela, et al.
Publicado: (2015)

Carvedilol improves glucose tolerance and insulin sensitivity in treatment of adrenergic overdrive in high fat diet-induced obesity in mice
por: Nguyen, Linh V., et al.
Publicado: (2019)

β-Adrenergic Receptor-Stimulated Cardiac Myocyte Apoptosis: Role of β1 Integrins
por: Amin, Parthiv, et al.
Publicado: (2011)

Androgen Effects on the Adrenergic System of the Vascular, Airway, and Cardiac Myocytes and Their Relevance in Pathological Processes
por: Carbajal-García, Abril, et al.
Publicado: (2020)

Adenosine A(2A) Receptors Are Upregulated in Peripheral Blood Mononuclear Cells from Atrial Fibrillation Patients
por: Godoy-Marín, Héctor, et al.
Publicado: (2021)

A Compartmentalized Mathematical Model of the β(1)-Adrenergic Signaling System in Mouse Ventricular Myocytes
por: Bondarenko, Vladimir E.
Publicado: (2014)

Carvedilol in hypertension treatment
por: Stafylas, Panagiotis C, et al.
Publicado: (2008)

E. coli infection disrupts the epithelial barrier and activates intrinsic neurosecretory reflexes in the pig colon
por: Traserra, Sara, et al.
Publicado: (2023)

Carvedilol—NSBB of Choice in All Cirrhotics? Short Title: Carvedilol for Portal Hypertension
por: Tandon, Puneeta, et al.
Publicado: (2015)

R-carvedilol, a potential new therapy for Alzheimer’s disease
por: Yao, Jinjing, et al.
Publicado: (2022)

Carvedilol in the treatment of chronic heart failure: Lessons from The Carvedilol Or Metoprolol European Trial
por: Kveiborg, Britt, et al.
Publicado: (2007)

Regulatory Volume Decrease of Cardiac Myocytes Induced by β-Adrenergic Activation of the Cl(−) Channel in Guinea Pig
por: Wang, Zhuren, et al.
Publicado: (1997)

Functional subcellular distribution of β(1)- and β(2)-adrenergic receptors in rat ventricular cardiac myocytes
por: Cros, Caroline, et al.
Publicado: (2013)

Clinical value of detecting autoantibodies against β(1)-, β(2),- and α(1)-adrenergic receptors in carvedilol treatment of patients with heart failure
por: Hou, Dong-Yan, et al.
Publicado: (2020)

Investigating Carvedilol’s Repurposing for the Treatment of Non-Small Cell Lung Cancer via Aldehyde Dehydrogenase Activity Modulation in the Presence of β-Adrenergic Agonists
por: Ikhmais, Balqis A., et al.
Publicado: (2023)

Corrigendum: R-carvedilol, a potential new therapy for Alzheimer’s disease
por: Yao, Jinjing, et al.
Publicado: (2023)

Use of carvedilol in hypertension: an update
por: Leonetti, Gastone, et al.
Publicado: (2012)

Carvedilol in the Treatment of Portal Hypertension
por: Al-Ghamdi, Hamdan
Publicado: (2011)

How Carvedilol activates β(2)-adrenoceptors
por: Benkel, Tobias, et al.
Publicado: (2022)

β-Adrenergic Stimulation Increases Cav3.1 Activity in Cardiac Myocytes through Protein Kinase A
por: Li, Yingxin, et al.
Publicado: (2012)

Male and female hypertrophic rat cardiac myocyte functional responses to ischemic stress and β-adrenergic challenge are different
por: Bell, James R., et al.
Publicado: (2016)

Carvedilol, an Adrenergic Blocker, Suppresses Melanin Synthesis by Inhibiting the cAMP/CREB Signaling Pathway in Human Melanocytes and Ex Vivo Human Skin Culture
por: Choi, Myoung Eun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_020a0j6qfr8fel0kodqa10c3qb